https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2042528&key=transthyretin+amyloidosis
News for Medical Sales Reps: Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen...
for medicalsales repsionis pharmaceuticalsnewsannounces
https://pharmaphorum.com/tag/ionis-pharmaceuticals
Ionis Pharmaceuticals | pharmaphorum
|Ionis Pharmaceuticals
ionis pharmaceuticalspharmaphorum
https://stockscan.io/stocks/IONS/option-chain
Ionis Pharmaceuticals Inc Stock (IONS) Option Chain - StockScan
Dive into the comprehensive IONS stock options chain and discover the flexibility and potential returns offered by Ionis Pharmaceuticals Inc stock (IONS)...
ionis pharmaceuticalsoption chainincstockions
https://newstodaydigest.com/beyond-the-numbers-10-analysts-discuss-ionis-pharmaceuticals-stock/
Beyond The Numbers: 10 Analysts Discuss Ionis Pharmaceuticals Stock - News Today Digest
Aug 22, 2025 - Latest Ratings for IONS Date Firm Action From To Mar 2022 Guggenheim Initiates Coverage On Buy Mar 2022 Citigroup Initiates Coverage On Sell Feb 2022 SVB...
beyond the numbersionis pharmaceuticalsstock newsanalystsdiscuss
https://adisinsight.springer.com/drugs/800058292?error=cookies_not_supported&code=d322d56f-386f-4215-a68c-534016bad9cb
Tonlamarsen - Ionis Pharmaceuticals - AdisInsight
Tonlamarsen (formerly ION 904) is a generation 2.5 ligand-conjugated (LICA) antisense oligonucleotide being developed by Ionis Pharmaceuticals for the treatment
ionis pharmaceuticals
https://finviz.com/quote?t=IONS&ta=1&p=m&ty=lf
IONS - Ionis Pharmaceuticals Inc Latest SEC Filings
IONS - Ionis Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
latest sec filingsionis pharmaceuticalsionsinc
https://flcube.com/?p=15404
Novartis AG and Ionis Pharmaceuticals Renew Collaboration on Lp(a)-Driven CVD Drug - Insight,...
Nov 28, 2024 - Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has returned to US-based Ionis Pharmaceuticals Inc., (NASDAQ: IONS) for a collaboration and license...
ionis pharmaceuticalsnovartisagrenewcollaboration
https://www.benzinga.com/general/biotech/23/09/34917947/ionis-pharmaceuticals-rare-metabolic-disorder-candidate-poised-to-become-new-standard-treatment-s
Why Ionis Pharmaceuticals (IONS) Stock Is Trading Higher Today - Ionis Pharmaceuticals...
Sep 26, 2023 - Ionis Pharmaceuticals Inc (NASDAQ: IONS) released topline results for the Phase 3 Balance study of olezarsen in people with familial chylomicronemia syndrome...
ionis pharmaceuticalsionsstocktradinghigher
https://www.financialcontent.com/quote/NQ:IONS/historical
Historical Stock Prices for Ionis Pharmaceuticals, Inc. - Common Stock (Nasdaq:IONS) |...
Daily Stock Prices for Ionis Pharmaceuticals, Inc. - Common Stock (Nasdaq:IONS), Including Open, High, Low, and Close for the past 25 years
stock pricesionis pharmaceuticalshistoricalinccommon
https://thelifesciencesmagazine.com/ionis-pharmaceuticals/
Ionis Pharmaceuticals Gains FDA Approval For RNA Therapy In Rare Disease Treatment | The...
Aug 24, 2025 - Ionis Pharmaceuticals' antisense platform differentiates itself from RNA interference (RNAi) technologies, such as those developed by Alnylam Pharmaceuticals.
ionis pharmaceuticalsfda approvalrna therapyrare diseasegains
https://www.ellis.com/visa-sponsors/ionis-pharmaceuticals-inc/h1b
Ionis Pharmaceuticals, Inc. LCA Filings & H1B Cases | Ellis
Ionis Pharmaceuticals, Inc. H1B visa sponsorship: 28 applications filed, 28 positions, $139,998 avg salary. Search individual cases, view wage levels, and...
ionis pharmaceuticalsinclcafilingscases
https://www.pharmiweb.com/press-release/2020-01-06/ionis-pharmaceuticals-to-present-at-38th-annual-jp-morgan-healthcare-conference
Ionis Pharmaceuticals to present at 38th annual J.P. Morgan Healthcare Conference - PharmiWeb.com
CARLSBAD, Calif., Jan. 6, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, today announced that Brett...
j p morganionis pharmaceuticalsto presenthealthcare conferenceannual
https://www.cmlviz.com/stocks/IONS/holders
IONS Institutional Buying and Selling - Ionis Pharmaceuticals Inc Common Stock Institutional...
Get the latest institutional holders transactions for Ionis Pharmaceuticals Inc. (IONS). Find out the total of holders shares held, purchased and sold.
buying and sellingionis pharmaceuticalscommon stockionsinstitutional
https://pl.bulios.com/ticker/0JDI.L
Ionis Pharmaceuticals, Inc. (0JDI.L) Stock | 0JDI.L Stock Price & Analysis - Bulios
Get the latest news and market analysis for Ionis Pharmaceuticals, Inc. (0JDI.L). Stay up-to-date on 0JDI.L Stock price and share price with Bulios. Explore...
ionis pharmaceuticalsstock priceincanalysisbulios
https://www.oxfordproperties.com/news/oxford-breaks-ground-on-165000-sq-ft-expansion-of-ionis-pharmaceuticals-carlsbad-campus
Oxford breaks ground on 165,000 sq ft expansion of Ionis Pharmaceuticals Carlsbad campus | Oxford...
ionis pharmaceuticalsoxfordbreaksgroundsq
https://pharma.economictimes.indiatimes.com/news/supply-chain-and-logistics/biogen-ionis-to-discontinue-development-of-experimental-als-drug/110317471
Ionis Pharmaceuticals: Biogen, Ionis to discontinue development of experimental ALS drug, ETPharma
Biogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their experimental treatment for amyotrophic lateral sclerosis (ALS)...
ionis pharmaceuticalsbiogendiscontinuedevelopmentexperimental
https://discovery.patsnap.com/company/ionis-pharmaceuticals/
Ionis Pharmaceuticals, Inc.:Company Profile & Technical Research,Competitor Monitor,Market Trends -...
ionis pharmaceuticalscompany profiletechnical researchmarket trendsinc
https://informaconnect.com/tides/speakers/jennifer-franklin/
Jennifer Franklin - Ionis Pharmaceuticals | TIDES USA: Oligonucleotide & Peptide Therapeutics...
ionis pharmaceuticalsjenniferfranklintidesusa
https://www.webull.com/news/13442269191782400
IONIS PHARMACEUTICALS INC : OPPENHEIMER RAISES TARGET PRICE TO $81 FROM $78
ionis pharmaceuticalsincoppenheimertargetprice
https://pocketoption.com/blog/en/news-events/signal/how-to-buy-ionis-pharmaceuticals/
How to buy Ionis Pharmaceuticals, Inc. (IONS) shares - Investment in Ionis Pharmaceuticals, Inc....
Aug 26, 2025 - Learn how to buy Ionis Pharmaceuticals, Inc. (IONS) shares with current price analysis, risk assessment, and step-by-step investment process for 2025...
how to buyionis pharmaceuticalsincionsshares
https://www.bmpharmaceuticals.com/gsk-walks-away-from-ionis-antisense-drugs/
GSK walks away from Ionis antisense drugs | B.M. Pharmaceuticals
b mgskwalksawaydrugs